Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated drivers, thereby enhancing safety.
Experts discuss the clinical and practical factors that guide decision-making when recommending continuous glucose monitoring (CGM) vs traditional glucose monitoring for patients with type 2 diabetes.
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Continuous Glucose Monitoring (CGM) is gaining attention as a tool for optimising dietary counselling in athletes. By ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Real-Time Glucose Monitoring Improves Blood Sugar Control in Type 1 and Type 2 Diabetes, Study Finds
"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...
EDINBURGH, Scotland, and SAN DIEGO – Tech, not medicine, is the future of care for Type 2 diabetes patients, according to a new report from Dexcom.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback